Compare Z & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | Z | LNTH |
|---|---|---|
| Founded | 2004 | 1956 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.0B | 6.7B |
| IPO Year | 2014 | 2014 |
| Metric | Z | LNTH |
|---|---|---|
| Price | $34.66 | $100.90 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 25 | 6 |
| Target Price | $79.45 | ★ $87.00 |
| AVG Volume (30 Days) | ★ 3.5M | 1.4M |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 118.75 | N/A |
| EPS | 0.18 | ★ 2.91 |
| Revenue | ★ $1,076,794,000.00 | $343,374,000.00 |
| Revenue This Year | $17.77 | N/A |
| Revenue Next Year | $13.31 | $14.19 |
| P/E Ratio | $196.19 | ★ $34.66 |
| Revenue Growth | ★ 27.19 | 3.62 |
| 52 Week Low | $29.23 | $49.67 |
| 52 Week High | $93.88 | $111.86 |
| Indicator | Z | LNTH |
|---|---|---|
| Relative Strength Index (RSI) | 52.51 | 47.12 |
| Support Level | $34.70 | $100.51 |
| Resistance Level | $37.21 | $102.66 |
| Average True Range (ATR) | 1.45 | 0.54 |
| MACD | -0.16 | 0.16 |
| Stochastic Oscillator | 49.22 | 60.62 |
Zillow Group Inc is a real estate technology company offering a digital platform that connects real estate customers with sellers, agents, loan officers, and other real estate-related professionals. With its tools and resources, Zillow helps real estate professionals grow their businesses, and for renters and housing providers, it offers a marketplace along with a set of end-to-end products and services to streamline applications, leases, payments, and more. The group operates various brands such as Zillow, Zillow Home Loans, Zillow Rentals, Zillow New Construction, Trulia, StreetEasy, Out East, HotPads, Follow Up Boss, ShowingTime, dotloop, and Zillow Closing. Its ecosystem spans the entire home journey from shopping to renting, buying, selling, and financing real estate.
Lantheus Holdings Inc is a radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver patient outcomes. The Company classifies its products into Radiopharmaceutical Oncology, Precision Diagnostics, and Strategic Partnerships and Other Revenue. Its products help healthcare professionals Find, Fight and Follow cancer and diseases and are used by physicians and technologists in clinical settings. The Company produces and markets its products in the United States, mainly to hospitals, independent imaging centers and government facilities, and sells outside the United States through direct and third-party distribution relationships and licensing arrangements in Europe, Canada, Australia, Asia-Pacific, Central America and South America.